Postoperative nausea and vomiting (PONV) is a debilitating condition that occurs in approximately 30% of patients undergoing general anesthesia. Premedication with 5-HT3 receptor antagonists and glucocorticoids is effective in clinical practice; however, 10% to 20% of patients still develop PONV. Currently, little is known about the treatment of refractory PONV. We present a case that illustrates the use of fosaprepitant for the treatment of refractory postoperative nausea and vomiting.
GanT.J.Risk factors for postoperative nausea and vomiting. Anesth Analg.2006; 102: 1884–1898.
2.
EberhartL.H., FrankS., LangeH.Systematic review on the recurrence of postoperative nausea and vomiting after a first episode in the recovery room: Implications for the treatment of PONV and related clinical trials. BMC Anesthesiol.2006; 6: 14.
3.
JokinenaJ., SmithA.F., RoewerN.Management of postoperative nausea and vomiting: How to deal with refractory PONV. Anesthesiology Clin.2012; 30: 481–493.
4.
KovacA.L., O'ConnorT.A., PearmanM.H.Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: A randomized, double-blind, placebo-controlled multicenter trial. J Clin Anesth.1999; 11: 453–459.
5.
DiemunschP., ApfelC., GanT.J.Preventing postoperative nausea and vomiting: Post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant. Curr Med Res Opin.2007; 23: 2559–2565.
6.
KakutaN., TsutsumiY.M., HorikawaY.T.Neurokinin-1 receptor antagonism, aprepitant, effectively diminishes post-operative nausea and vomiting while increasing analgesic tolerance in laparoscopic gynecological procedures. J Med Invest.2011; 58: 246–251.
7.
HartrickC.T., TangY.S., HunstadD.Aprepitant vs. multimodal prophylaxis in the prevention of nausea and vomiting following extended-release epidural morphine. Pain Tract.2010; 10: 245–248.
8.
BergeseS., ViloriaA., UribeA.Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: Study protocol for a randomized controlled trial. Trials.2012; 13: 130.
